LRIG1
Basic information
Region (hg38): 3:66378797-66501263
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LRIG1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 19 | 27 | ||||
missense | 81 | 13 | 18 | 112 | ||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 2 | |||||
Total | 0 | 0 | 81 | 32 | 28 |
Variants in LRIG1
This is a list of pathogenic ClinVar variants found in the LRIG1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-66380318-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
3-66380358-G-T | not specified | Uncertain significance (Aug 19, 2023) | ||
3-66380387-T-G | not specified • LRIG1-related disorder | Benign (Mar 29, 2016) | ||
3-66380396-G-A | not specified | Uncertain significance (Jan 25, 2023) | ||
3-66380403-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
3-66380446-G-A | LRIG1-related disorder | Benign (Feb 19, 2019) | ||
3-66380453-G-C | LRIG1-related disorder | Benign (Feb 21, 2019) | ||
3-66380474-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
3-66380483-G-T | not specified | Uncertain significance (Dec 08, 2023) | ||
3-66380601-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
3-66380631-C-T | Likely benign (Jul 31, 2018) | |||
3-66380635-G-C | LRIG1-related disorder | Benign (Nov 11, 2019) | ||
3-66380643-G-T | not specified | Uncertain significance (Aug 22, 2023) | ||
3-66380646-A-G | not specified | Uncertain significance (Dec 06, 2023) | ||
3-66380680-G-A | LRIG1-related disorder | Benign (May 15, 2018) | ||
3-66380720-T-A | Likely benign (Feb 01, 2023) | |||
3-66380733-G-A | not specified | Uncertain significance (Dec 06, 2023) | ||
3-66380737-C-T | LRIG1-related disorder | Benign (Aug 09, 2019) | ||
3-66380738-G-A | not specified | Uncertain significance (Feb 10, 2023) | ||
3-66380750-G-T | not specified | Uncertain significance (Mar 31, 2024) | ||
3-66380763-C-T | LRIG1-related disorder | Benign (Nov 06, 2019) | ||
3-66380788-G-T | not specified | Uncertain significance (Mar 15, 2024) | ||
3-66380813-C-G | not specified | Likely benign (Jul 25, 2023) | ||
3-66380813-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
3-66380824-G-A | LRIG1-related disorder | Likely benign (Mar 18, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LRIG1 | protein_coding | protein_coding | ENST00000273261 | 19 | 122467 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0350 | 0.965 | 125484 | 1 | 263 | 125748 | 0.00105 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.18 | 719 | 636 | 1.13 | 0.0000392 | 7077 |
Missense in Polyphen | 130 | 166.52 | 0.78068 | 1948 | ||
Synonymous | -5.51 | 394 | 277 | 1.42 | 0.0000190 | 2250 |
Loss of Function | 4.61 | 12 | 45.6 | 0.263 | 0.00000248 | 511 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000848 | 0.000847 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00106 | 0.00106 |
European (Non-Finnish) | 0.00165 | 0.00164 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000915 | 0.000882 |
Other | 0.00130 | 0.00130 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation. {ECO:0000269|PubMed:15282549}.;
- Pathway
- EGF-Ncore;Signal Transduction;ErbB4 signaling events;Signaling by EGFR;Negative regulation of MET activity;Signaling by MET;Signaling by Receptor Tyrosine Kinases;Internalization of ErbB1
(Consensus)
Recessive Scores
- pRec
- 0.205
Intolerance Scores
- loftool
- 0.483
- rvis_EVS
- 0.33
- rvis_percentile_EVS
- 73.54
Haploinsufficiency Scores
- pHI
- 0.744
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.459
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.965
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Lrig1
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; skeleton phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; vision/eye phenotype; immune system phenotype;
Gene ontology
- Biological process
- sensory perception of sound;hair cycle process;otolith morphogenesis;innervation
- Cellular component
- extracellular space;plasma membrane;integral component of membrane;extracellular matrix
- Molecular function